国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
门诊处方中老年人潜在不适当用药评价及不同标准应用研究
Evaluation and Application Research of Different Criteria for Potentially Inappropriate Medications in Elderly Outpatient Prescriptions
  
DOI:
中文关键词:  老年人  潜在不适当用药  用药评价  Beers标准  STOPP标准
英文关键词:The elderly  Potentially inappropriate medications  Drug evaluation  Beers criteria  STOPP criteria
基金项目:2017年军事医学创新专项(编号:17CXZ010)
作者单位
王茹1 郭代红1 李渊源1 施华宇2 解放军总医院 1.药学部2. 信息科 北京 100853 
摘要点击次数: 1429
全文下载次数: 1728
中文摘要:
      摘 要 目的:分析门诊处方中老年人潜在不适当用药(PIM)情况及相关因素,为老年人合理用药提供参考依据。方法:采用回顾性研究方法,分别应用中国、Beers和STOPP三种标准,对门诊老年人的基本情况(年龄、性别、住院号、付费方式)、临床诊断、治疗药物等用药信息进行统计分析和评价。 结果:13 175例患者的47 104条处方信息中,属于老年人PIM的筛选例数分别为:中国标准2 415例(18.33%),Beers标准2 475例(18.79%),STOPP标准406例(3.08%);频次排序靠前的相关药物为氢氯吡格雷、单硝酸异山梨酯、阿司匹林、艾司唑仑等。中国与Beers标准评价结果存在一致性(Kappa=0.453,P<0.05);年龄≥80岁、合并疾病≥2种、药品种类≥5种等因素是老年人PIM的独立危险因素(P<0.05)。结论:选用中国标准开展老年人PIM评价所得结果与Beers标准相近;中国标准再修改时有必要参考借鉴STOPP标准。药物治疗过程中对于年龄≥80岁、合并疾病≥2种、用药≥10种的老年人,应重点关注PIM可能导致的药品不良事件。
英文摘要:
      ABSTRACT Objective: To analyze the potentially inappropriate medication (PIM) and its related factors of elderly outpatient prescriptions, we made this research to provide reference for rational drug treatments in the elderly. Methods:Based on Chinese criteria, Beers criteria and STOPP criteria, basic condition (age, gender, hospital number, payment method), clinical diagnosis, and treatment medication of outpatients retrospectively extracted were evaluated and analyzed. Results: In 13 175 elderly patients from 47 104 prescription informations, the number of elderly PIM screening cases were: Chinese criteria 2 415 (18.33%), Beers criteria 2 475 (18.79%), and STOPP criteria 406 (3.08%). The ranking frequency of the top elderly PIM drugs was preceded by clopidogrel, isosorbide mononitrate, aspirin, and estazolam etc. The evaluation results between Chinese criteria and Beers criteria were consistent (Kappa=0.453,P<0.05); Aged ≥80 years old, comorbid disease ≥2, drug types ≥5 kinds, etc. were independent risk factors for elderly PIM (P<0.05). Conclusion: The results evaluated by using Chinese criteria for elderly PIM were similar to those evaluated by Beers criteria. It was necessary to refer to STOPP criteria when revising Chinese criteria. During drug treatments, attention should be paid to adverse drug events probably caused by PIM for the elderly who were over 80 years old, with comorbidities, and with multidrug treatments (≥10).
查看全文  查看/发表评论  下载PDF阅读器
关闭